Petra Vinken

936 total citations
31 papers, 663 citations indexed

About

Petra Vinken is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Petra Vinken has authored 31 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Petra Vinken's work include Drug Transport and Resistance Mechanisms (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatitis Pathology and Treatment (2 papers). Petra Vinken is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Diabetes Treatment and Management (3 papers) and Pancreatitis Pathology and Treatment (2 papers). Petra Vinken collaborates with scholars based in Belgium, United States and United Kingdom. Petra Vinken's co-authors include Xavier Langlois, Julie Andrews, R. De Coster, Anton A. H. P. Megens, Shitij Kapur, Sofie Starckx, Ann Lampo, Manisha Sonee, Sandra De Jonghe and Masayuki Sugiura and has published in prestigious journals such as Cancer Research, Pain and Journal of Medicinal Chemistry.

In The Last Decade

Petra Vinken

29 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Vinken Belgium 13 223 122 116 103 78 31 663
Cláudia Lúcia Martins Silva Brazil 17 271 1.2× 58 0.5× 51 0.4× 39 0.4× 30 0.4× 45 922
Patrick B. Kyle United States 17 201 0.9× 52 0.4× 193 1.7× 35 0.3× 64 0.8× 48 816
Jiang‐Rui Zhou China 13 216 1.0× 50 0.4× 68 0.6× 40 0.4× 136 1.7× 16 658
Jukka Tenhunen Finland 14 409 1.8× 80 0.7× 173 1.5× 144 1.4× 23 0.3× 18 1.0k
Shuja Shafi Malik Saudi Arabia 14 443 2.0× 47 0.4× 104 0.9× 77 0.7× 16 0.2× 36 916
Chiung-Wen Tsao Taiwan 16 273 1.2× 33 0.3× 79 0.7× 35 0.3× 122 1.6× 23 715
Yoshito Takahashi Japan 13 143 0.6× 101 0.8× 102 0.9× 120 1.2× 13 0.2× 48 929
Belisario E. Fernández Argentina 18 352 1.6× 259 2.1× 154 1.3× 39 0.4× 28 0.4× 96 1.1k
Gaia Cuomo Italy 7 147 0.7× 244 2.0× 80 0.7× 40 0.4× 23 0.3× 7 765
Tiziano Balzano Spain 20 293 1.3× 28 0.2× 171 1.5× 68 0.7× 20 0.3× 31 1.1k

Countries citing papers authored by Petra Vinken

Since Specialization
Citations

This map shows the geographic impact of Petra Vinken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Vinken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Vinken more than expected).

Fields of papers citing papers by Petra Vinken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Vinken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Vinken. The network helps show where Petra Vinken may publish in the future.

Co-authorship network of co-authors of Petra Vinken

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Vinken. A scholar is included among the top collaborators of Petra Vinken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Vinken. Petra Vinken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Romanov‐Michailidis, Fedor, Chien‐Chi Hsiao, Bradley S. Miller, et al.. (2023). Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein–Protein Interaction Modulator with the Potential of Treating Hematological Malignancies. Journal of Medicinal Chemistry. 66(9). 6122–6148. 16 indexed citations
4.
Thomson, Paul, Xiaoli Meng, Jan Snoeys, et al.. (2020). Drug‐specific T‐cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat. Allergy. 76(6). 1825–1835. 15 indexed citations
5.
Erkens, Tim, et al.. (2018). Analytical performance of a commercial multiplex Luminex-based cytokine panel in the rat. Journal of Pharmacological and Toxicological Methods. 91. 43–49. 2 indexed citations
6.
Wu, Tongfei, Hillary J. Millar, Dana Gaffney, et al.. (2018). Abstract 4859: JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potent in vitro and in vivo activity, demonstrated in several lung cancer models. Cancer Research. 78(13_Supplement). 4859–4859. 21 indexed citations
7.
8.
Lagatie, Ole, Emmanuel Njumbe Ediage, Linda Batsa Debrah, et al.. (2016). Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection. Parasites & Vectors. 9(1). 302–302. 20 indexed citations
9.
Jonghe, Sandra De, et al.. (2015). Bilateral Symmetrical Idiopathic Necrotizing Encephalopathy. Toxicologic Pathology. 43(8). 1141–1148. 1 indexed citations
10.
Vinken, Petra, William J. Reagan, Wayne R. Buck, et al.. (2015). Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in rat. Journal of Pharmacological and Toxicological Methods. 77. 58–65. 8 indexed citations
11.
Jonghe, Sandra De, Petra Vinken, Bianca Feyen, et al.. (2014). Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin. Chemico-Biological Interactions. 224. 1–12. 43 indexed citations
12.
Mamidi, Rao N. V. S., Sandra De Jonghe, Bianca Feyen, et al.. (2014). Carbohydrate malabsorption mechanism for tumor formation in rats treated with the SGLT2 inhibitor canagliflozin. Chemico-Biological Interactions. 221. 109–118. 17 indexed citations
13.
La, David, Dianne M. Creasy, Rex A. Hess, et al.. (2012). Efferent Duct Toxicity with Secondary Testicular Changes in Rats Following Administration of a Novel Leukotriene A4 Hydrolase Inhibitor. Toxicologic Pathology. 40(5). 705–714. 10 indexed citations
14.
Vinken, Petra, et al.. (2012). Tissue Kim-1 and Urinary Clusterin as Early Indicators of Cisplatin-Induced Acute Kidney Injury in Rats. Toxicologic Pathology. 40(7). 1049–1062. 75 indexed citations
15.
Waal, Eric J. De, et al.. (2012). Mechanistic investigations on the etiology of Risperdal® Consta®-induced bone changes in female Wistar Hannover rats. Toxicology. 299(2-3). 90–98. 9 indexed citations
16.
Langlois, Xavier, A. Frans, Anton A. H. P. Megens, et al.. (2006). Pharmacology of aripiprazole in rats: A comparison with the classical neuroleptic haloperidol. The International Journal of Neuropsychopharmacology. 9. 1 indexed citations
17.
Snijdelaar, Dirk G., Clementina M. van Rijn, Petra Vinken, & Theo Meert. (2005). Effects of pre-treatment with amantadine on morphine induced antinociception during second phase formalin responses in rats. Pain. 119(1-3). 159–167. 13 indexed citations
18.
Vissers, Kris, et al.. (2003). Adrenalectomy affects pain behavior of rats after formalin injection. Life Sciences. 74(10). 1243–1251. 28 indexed citations
19.
Chaki, Shigeyuki, Atsuro Nakazato, Ludo Kennis, et al.. (2003). Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. European Journal of Pharmacology. 485(1-3). 145–158. 103 indexed citations
20.
Kapur, Shitij, Xavier Langlois, Petra Vinken, et al.. (2002). The Differential Effects of Atypical Antipsychotics on Prolactin Elevation Are Explained by Their Differential Blood-Brain Disposition: A Pharmacological Analysis in Rats. Journal of Pharmacology and Experimental Therapeutics. 302(3). 1129–1134. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cláudia Lúcia Martins Silva Breakdown of academic impact, for papers by Patrick B. Kyle Breakdown of academic impact, for papers by Jiang‐Rui Zhou Breakdown of academic impact, for papers by Jukka Tenhunen Breakdown of academic impact, for papers by Shuja Shafi Malik Breakdown of academic impact, for papers by Chiung-Wen Tsao Breakdown of academic impact, for papers by Yoshito Takahashi Breakdown of academic impact, for papers by Belisario E. Fernández Breakdown of academic impact, for papers by Gaia Cuomo Breakdown of academic impact, for papers by Tiziano Balzano
Rankless by CCL
2026